Climb Bio Inc (CLYM)

Profile

Full Name

Climb Bio Inc

Ticker

NASDAQ: CLYM

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

Indexes

Not included

Website

https://climbbio.com

Employees

17

Key Details

Price

$2.11(+11.05%)

Market cap

$142.98M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$1.53(-17.69% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.11
    CLYM price is $2.11

    30-Day Relative Volume

    3.16
    CLYM 30-day relative volume is 3.16

    Price Performance

    Price Most recent change

    +11.05%
    CLYM price was up +11.05% on Aug 18, 2025

    Price YTD change

    +17.22%
    CLYM price is up +17.22% since January 1st

    Price 1-year change

    -65.52%
    CLYM price is down -65.52% year-on-year

    Price 3-year change

    -27.49%
    CLYM price is down -27.49% over the past 3 years

    Price Range

    Price All-time high

    $29.69
    CLYM price is currently -92.89% below its historical high of $29.69

    Price 3-year low

    $1.05
    CLYM price is currently +100.95% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $142.98M
    CLYM market capitalization is $142.98 million

    Market cap 3-year change

    +84.94%
    CLYM market capitalization is up +84.94% over the past 3 years

    Market cap All-time high

    $759.54M
    CLYM market capitalization is currently -81.18% below its historical high of $759.54 million

    Market cap sector rank

    46.68%
    CLYM market capitalization is higher than 46.68% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.05%
    CLYM shares outstanding is up +1.05% year-on-year

    Shares Outstanding 3-Year Change

    +155.06%
    CLYM shares outstanding is up +155.06% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.10
    CLYM beta is 1.10

    200-day SMA

    $1.79
    CLYM price is currently +17.90% above its 200-day simple moving average

    50-day SMA

    $1.43
    CLYM price is currently +47.22% above its 50-day simple moving average

    RSI

    75.46
    CLYM 14-day relative strength index is 75.46

    Volume

    3.16
    CLYM 30-day relative volume is 3.16

    ATR

    $0.15
    CLYM average true range is $0.15

    10-day Historical Volatility

    83.41%
    CLYM 10-day historical volatility is 83.41%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    CLYM annual revenue is $0.00

    Revenue Analysts estimate

    -
    CLYM annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    CLYM annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.58%
    CLYM annual revenue is higher than 28.58% of companies in Healthcare sector

    EPS

    EPS

    -$1.53
    CLYM annual earnings per share is -$1.53

    EPS Analysts estimate

    -$0.74
    CLYM annual earnings per share is currently +106.06% higher than the consensus analysts' forecast

    EPS 1-year change

    -17.69%
    CLYM annual earnings per share is down -17.69% year-on-year

    EPS Sector rank

    42.36%
    CLYM annual earnings per share is higher than 42.36% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    CLYM annual gross profit is $0.00

    Gross margin

    -
    CLYM annual gross profit margin value is unknown

    Operating profit

    -$30.36M
    CLYM annual operating income is -$30.36 million

    Operating margin

    -
    CLYM annual operating profit margin value is unknown

    Net income

    -$73.90M
    CLYM annual net profit is -$73.90 million

    Net margin

    -
    CLYM annual net profit margin value is unknown

    Expenses

    Total expenses

    $30.36M
    CLYM annual total expenses is $30.36 million

    Operating expenses

    $30.36M
    CLYM annual total operating expenses is $30.36 million

    Cost of goods sold

    $0.00
    CLYM annual cost of goods sold is $0.00

    Selling, general & administrative expenses

    $16.02M
    CLYM annual SGA is $16.02 million

    Depreciation and amortization

    -
    CLYM annual depreciation & amortization value is unknown

    Interest expense

    $0.00
    CLYM annual interest expense is $0.00

    Income tax

    $0.00
    CLYM annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$30.36M
    CLYM annual earnings before interest & taxes is -$30.36 million

    EBITDA

    -$30.36M
    CLYM annual EBITDA is -$30.36 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $217.19M
    CLYM annual total assets is $217.19 million

    Non current assets

    $62.31M
    CLYM annual long term assets is $62.31 million

    Current assets

    $154.87M
    CLYM annual total current assets is $154.87 million

    Cash and cash equivalents

    $87.23M
    CLYM annual cash & cash equivalents is $87.23 million

    Accounts receivable

    -
    CLYM annual accounts receivable value is unknown

    Inventory

    $0.00
    CLYM annual inventory is $0.00

    Liabilities

    Total liabilities

    $5.31M
    CLYM annual total liabilities is $5.31 million

    Long term liabilities

    $375.00K
    CLYM annual total long term liabilities is $375.00 thousand

    Current liabilities

    $4.93M
    CLYM annual total current liabilities is $4.93 million

    Accounts payable

    $705.00K
    CLYM annual accounts payable is $705.00 thousand

    Debt

    Total debt

    $532.00K
    CLYM annual total debt is $532.00 thousand

    Total debt 1-year change

    +52.44%
    CLYM annual total debt is up +52.44% year-on-year

    Long term debt

    $375.00K
    CLYM annual long term debt is $375.00 thousand

    Short term debt

    $157.00K
    CLYM annual short term debt is $157.00 thousand

    Equity & Capital

    Shareholders equity

    $211.88M
    CLYM annual stockholders equity is $211.88 million

    Book value

    $211.88M
    CLYM annual book value is $211.88 million

    Retained earnings

    -$229.88M
    CLYM annual retained earnings is -$229.88 million

    Working capital

    $149.94M
    CLYM annual working capital is $149.94 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$15.56M
    CLYM annual cash flow from operations is -$15.56 million

    Cash from operations 1-year change

    +24.45%
    CLYM annual cash flow from operations is up +24.45% year-on-year

    Cash from investing

    -$121.09M
    CLYM annual cash flow from investing activities is -$121.09 million

    Cash from investing 1-year change

    -275.54%
    CLYM annual cash flow from investing activities is down -275.54% year-on-year

    Cash from financing

    $130.73M
    CLYM annual cash flow from financing activities is $130.73 million

    Cash from financing 1-year change

    +15444.47%
    CLYM annual cash flow from financing activities is up +15444.47% year-on-year

    CAPEX

    CAPEX

    $0.00
    CLYM annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    CLYM annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$15.56M
    CLYM annual free cash flow is -$15.56 million

    Free cash flow 1-year change

    +24.45%
    CLYM annual free cash flow is up +24.45% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CLYM annual gross profit margin value is unknown

    Operating margin

    -
    CLYM annual operating profit margin value is unknown

    Net margin

    -
    CLYM annual net profit margin value is unknown

    ROA & ROE

    ROA

    -45.11%
    CLYM annual return on assets is -45.11%

    ROE

    -46.26%
    CLYM annual return on equity is -46.26%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CLYM price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CLYM price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.77
    CLYM price to book ratio is 0.77

    PB ratio Sector rank

    31.26%
    CLYM price to book ratio is higher than 31.26% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CLYM price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CLYM price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $58.28M
    CLYM enterprise value is $58.28 million

    Enterprise value Sector rank

    43.91%
    CLYM enterprise value is higher than 43.91% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.10
    CLYM EV/EBITDA is -1.10

    EV/EBITDA Sector rank

    43.62%
    CLYM EV/EBITDA is higher than 43.62% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    31.41
    CLYM annual current ratio is 31.41

    Quick ratio

    31.41
    CLYM annual quick ratio is 31.41

    Leverage

    Debt to equity

    0.00
    CLYM annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CLYM annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CLYM piotroski f-score value is unknown

    Altman Z-Score

    15.05
    CLYM altman z-score is 15.05

    Analyst ratings

    Recent major analysts updates

    Aug 15, 25 Baird
    Outperform
    Jun 6, 25 Oppenheimer
    Outperform

    Institutional Ownership

    Screeners with CLYM included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Climb Bio Inc?
    • Does Climb Bio Inc pay dividends?
    • What sector is Climb Bio Inc in?
    • What industry is Climb Bio Inc in?
    • What country is Climb Bio Inc based in?
    • Is Climb Bio Inc in the S&P 500?
    • Is Climb Bio Inc in the NASDAQ 100?
    • Is Climb Bio Inc in the Dow Jones?
    • When was Climb Bio Inc's last earnings report?
    • When does Climb Bio Inc report earnings?

    What is the ticker symbol for Climb Bio Inc?

    The ticker symbol for Climb Bio Inc is NASDAQ:CLYM

    Does Climb Bio Inc pay dividends?

    No, Climb Bio Inc does not pay dividends

    What sector is Climb Bio Inc in?

    Climb Bio Inc is in the Healthcare sector

    What industry is Climb Bio Inc in?

    Climb Bio Inc is in the Biotechnology industry

    What country is Climb Bio Inc based in?

    Climb Bio Inc is headquartered in United States

    Is Climb Bio Inc in the S&P 500?

    No, Climb Bio Inc is not included in the S&P 500 index

    Is Climb Bio Inc in the NASDAQ 100?

    No, Climb Bio Inc is not included in the NASDAQ 100 index

    Is Climb Bio Inc in the Dow Jones?

    No, Climb Bio Inc is not included in the Dow Jones index

    When was Climb Bio Inc's last earnings report?

    Climb Bio Inc's most recent earnings report was on August 14, 2025

    When does Climb Bio Inc report earnings?

    The date for Climb Bio Inc's next earnings report has not been announced yet
    On this page